AKT1 and breast cancer: In addition, Nobiletin decreases the expression of Bcl-2, Bcl-xL, increases the expression of Bax, p53, and caspase-3, and inhibits the Akt/mTOR pathway to induce apoptosis of BC cells and suppress the progression of BC [191, 192].